Freddy Heitz
Impact in
- Clinical Biochemistry top 2%
- Advanced Glycation End Products research
- Immunology top 5%
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
Papers in
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 9
-
- Mitochondrial Function and Pathology 5
- Muscle Physiology and Disorders 2
- Peroxisome Proliferator-Activated Receptors 1
- Co-authors
- Cédric Szyndralewiez (10 shared papers)Patrick Page (6 shared papers)Karin Jandeleit‐Dahm (3 shared papers)Rhian M. Touyz (3 shared papers)Mark E. Cooper (3 shared papers)Cédric Merlot (3 shared papers)Benoı̂t Laleu (3 shared papers)Francesca Gaggini (3 shared papers)
- Journals
- PLoS ONE (2 papers)Journal of Medicinal Chemistry (1 paper)Hepatology (1 paper)Free Radical Biology and Medicine (1 paper)SLAS DISCOVERY (1 paper)
- Partner nations
- SwitzerlandItalyUnited Kingdom
In The Last Decade
Freddy Heitz
16 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 87
- Clinical Biochemistry 215
- Immunology 651
- Nephrology 159
- Physiology 513
- Neurology 115
Countries citing papers authored by Freddy Heitz
This map shows the geographic impact of Freddy Heitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Freddy Heitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Freddy Heitz more than expected).
Fields of papers citing papers by Freddy Heitz
This network shows the impact of papers produced by Freddy Heitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Freddy Heitz. The network helps show where Freddy Heitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Freddy Heitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 323 | |
| 2 | 2014 | 296 | |
| 3 | 2012 | 271 | |
| 4 | 2010 | 207 | |
| 5 | 2016 | 140 | |
| 6 | 2012 | 135 | |
| 7 | 2011 | 129 | |
| 8 | 2017 | 93 | |
| 9 | 2011 | 68 | |
| 10 | 2009 | 34 | |
| 11 | 2011 | 34 | |
| 12 | 2019 | 29 | |
| 13 | 2013 | 12 | |
| 14 | Drug discovery and development for Huntington's disease - an orphan indication with high medical need. | 2008 | 7 |
| 15 | 2013 | 6 | |
| 16 | 2007 | 3 |
About Freddy Heitz
Freddy Heitz is a scholar working on Immunology, Molecular Biology, Cellular and Molecular Neuroscience, Physiology and Infectious Diseases, having authored 16 papers that have together received 1.8k indexed citations. Recurring topics across this work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (9 papers), Mitochondrial Function and Pathology (5 papers), Genetic Neurodegenerative Diseases (5 papers), Nitric Oxide and Endothelin Effects (3 papers), Muscle Physiology and Disorders (2 papers), Antifungal resistance and susceptibility (2 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Peroxisome Proliferator-Activated Receptors (1 paper). The work is most often cited by research in Clinical Biochemistry (215 citations), Immunology (651 citations), Nephrology (159 citations), Physiology (513 citations) and Neurology (115 citations). Freddy Heitz has collaborated with scholars based in Switzerland, Italy and United Kingdom. Frequent co-authors include Cédric Szyndralewiez, Patrick Page, Karin Jandeleit‐Dahm, Rhian M. Touyz, Mark E. Cooper, Cédric Merlot, Benoı̂t Laleu, Francesca Gaggini, Assam El‐Osta and Kirstin Wingler. Their work appears in journals such as PLoS ONE, Journal of Medicinal Chemistry, Hepatology, Free Radical Biology and Medicine and SLAS DISCOVERY.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.